Chief Technology Officer, Managing Director & Co-Founder, ions.bio
BIOGRAPHY
Speaker
Event Date & Time
Date: October 21, 2025
Time: 9:00 AM (PST), 12:00 PM (EST), 6:00 PM (CET)
Abstract
Plasma proteomics offers great promise for biomarker discovery, due to the accessibility and diagnostic relevance of blood plasma. Recent advances in instrumentation, particularly the Orbitrap Astral mass spectrometer, now enable unprecedented depth, with over 1,000 proteins routinely quantified directly in neat plasma, without the need for depletion or fractionation. This development is transforming the landscape of high-throughput biomarker research.
In addition, nanoparticle- or precipitation-based enrichment workflows can further expand proteome coverage, offering orthogonal strategies to access low-abundance proteins and diverse functional subsets. However, all these approaches remain highly susceptible to pre-analytical variation. Factors such as sample collection, handling, and storage can introduce significant bias, confounding both discovery and interpretation. Therefore, rigorous standardization and quality control are critical to ensure reproducibility and biological relevance.
We will illustrate both the challenges and opportunities of plasma biomarker discovery using two example cohorts: one from bariatric surgery and one from patients with Giant Cell Arteritis. Together, these case studies highlight how deep plasma proteomics can uncover disease-relevant signals, while also underscoring the need for methodological care to ensure robust biological insights.
Learning Objectives:
- Understand the analytical challenges of plasma biomarker discovery for cohort studies
- Learn about technology advancements to improve depth and throughput for plasma biomarker discovery
- How to apply best practices for standardization and quality control in plasma proteomics
- What workflow developments can be leveraged to uncover disease relevant signals in sample cohorts
Webinars will be available for unlimited on-demand viewing after live event.
You May Also Like
OCT 02, 2025 | 8:00 AM
CAR-T Therapy continues to evolve rapidly, mRNA encoding CAR constructs directly to T cells in the bloodstream, potentially enabling CAR T cell production in the body without the need to iso...
OCT 07, 2025 | 7:00 AM
This presentation explores the scientific rationale, preclinical validation, and early clinical translation of STAR-LLD—a novel, continuous low-dose percutaneous lenalidomide delivery...
OCT 07, 2025 | 7:00 AM
The analysis of protein behavior and protein interactions is central in drug research. In this web seminar, we will show you how the automation of protein purification and downstream thermal...
OCT 07, 2025 | 11:00 AM
Mass Photometry (MP) and Macro Mass Photometry (MMP) are complementary, label-free techniques that analyze biomolecules and therapeutic vectors directly in solution with single-particle reso...
OCT 08, 2025 | 9:00 AM
Cell counting is a fundamental step in many workflows, including cell culture, cell analysis, transfection, single cell sequencing, and cell therapy. Automated cell counters have improved th...
OCT 09, 2025 | 8:07 AM
At Evotec, we turn great science into real-world medicines; faster, smarter and at exceptional quality. We partner with biotech, pharma and academic institutions to deliver from disease unde...
Loading Comments...